Only comments seeking to improve the quality and accuracy of information on the Orphanet website are accepted. For all other comments, please send your remarks via contact us. Only comments written in English can be processed. An Orphanet summary for this disease is currently under development. However, other data related to the disease are accessible from the Additional Information menu located at the bottom of this page.
|Published (Last):||24 September 2019|
|PDF File Size:||8.77 Mb|
|ePub File Size:||15.71 Mb|
|Price:||Free* [*Free Regsitration Required]|
Hidradenitis suppurativa is a chronic debilitating and stigmatizing disease that is difficult to treat. The disease presents several clinical characteristics, which may occur alone or simultaneously in various locations, generally symmetrical and distributed in the "milk line". It affects the following areas of the skin where intertriginous apocrine glands are numerous, in the descending order: axilla, anogenital region, areolas, and inframammary crease.
The lesions often drain foul purulent exudate, with significant damage to quality of life. As the disease progresses, formation of fistulas, comedones, fibrosis, dermal contractures, and hardening of the skin occur. The highest chances of cure are lie in early diagnosis and individualized treatment, which covers pharmacological, behavioral, and surgical measures.
Surgical treatment has been considered a more effective curative measure. The decision between the different modalities will depend on the stage, presentation, and local commitment and include incision and drainage of abscesses, deroofing, marsupialization, electrosurgery, Nd:YAG laser, CO 2 laser, and extensive surgical excision.
The reconstruction options include healing by second intention, immediate or delayed full-thickness skin graft, primary closure, and flaps. The reported case of presternal injuries presented clinical and histological characteristics compatible with hidradenitis suppurativa; this location has been rarely reported in the literature.
The postoperative results of complete resection of the lesion with primary closure indicated resolution over a long follow-up period. More randomized clinical trials are needed to determine the best management strategy for hidradenitis suppurativa. All scientific articles published at www. Previous Article Next Article.
Figure 1. Preoperative aspect. Figure 2. Surgical excision after catheterization of the orifice with resection up to the limit of the periosteum. Figure 3. Intraoperative aspect. Figure 4. Surgical specimen showing the anatomical planes.
Figure 5. Postoperative aspect with an aspiration tube for later intermittent flushing with saline for 7 days. Figure 6. Three-year postoperative aspect. Figure 7. Three-year postoperative aspect: close.
Fatores de risco para hidradenite supurativa: um estudo piloto. Mailing address. The hidradenitis suppurativa is a chronic debilitating inflammatory disease whose etiology is not fully understood. We conducted a pilot case-control study matched by sex and age with other dermatological patients to analyze possible risk factors associated with this disease. Bivariate and multivariate logistic regression analysis identified significant association with smoking, higher body mass index and family history. The use of hormonal contraceptives was less frequent in women with hidradenitis. Keywords: Hidradenitis suppurativa; Obesity; Risk factors; Smoking.
However, complete HS resolution can be achieved through surgical treatment. A series of patients with HS complications is described herein, along with their evolution and complications after complete axillary surgical resection and lateral thoracic fasciocutaneous flap rotation. The evaluation of associated affected areas is also reported. All patients had long-standing, chronic axillary lesions that were refractory to non-surgical treatment.